Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

While some therapies seem to have benefit earlier and earlier in the disease course, docetaxel doesn’t seem to be one of them. No benefit

  • While some therapies seem to have benefit earlier and earlier in the disease course, docetaxel doesn’t seem to be one of them. No benefit in OS when docetaxel added to radiation and ADT in unfavorable risk prostate cancer.